Personal information

Medulloblastoma, immunotherapy, molecular biology, pediatric brain tumor, angiogenesis, mouse models
United States

Activities

Employment (1)

Harvard Medical School: Boston, MA, US

2014-11-01 to present | Postdoctoral Fellow
Employment
Source: Self-asserted source
Sampurna Chatterjee

Education and qualifications (1)

Max-Planck-Institut für neurologische Forschung: Koln, Nordrhein-Westfalen, DE

2010-01-15 to 2014-04-18 | PhD
Education
Source: Self-asserted source
Sampurna Chatterjee

Funding (1)

Combined immune checkpoint blockade with chemotherapy improves therapeutic outcome in GBM

2015-07 to present | Grant
American Brain Tumor Association (IL, IL, US)
GRANT_NUMBER: undefined id
Source: Self-asserted source
Sampurna Chatterjee

Works (9)

Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes

Journal of Experimental Medicine
2023-09-04 | Journal article
Contributors: Pin-Ji Lei; Ethel R. Pereira; Patrik Andersson; Zohreh Amoozgar; Jan Willem Van Wijnbergen; Meghan J. O’Melia; Hengbo Zhou; Sampurna Chatterjee; William W. Ho; Jessica M. Posada et al.
Source: check_circle
Crossref

Review of: "Is SARS-CoV-2 Spike glycoprotein impairing macrophage polarization via α7-nicotinic acetylcholine receptors?"

Qeios
2021-04-18 | Journal article
Contributors: Sampurna Chatterjee
Source: check_circle
Crossref

Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer.

2015-11 | Journal article
Contributors: Schöttle J; Chatterjee S; Volz C; Siobal M; Florin A; Rokitta D; Hinze Y; Dietlein F; Plenker D; König K et al.
Source: Self-asserted source
Sampurna Chatterjee via Europe PubMed Central

The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.

2014-06 | Journal article
Contributors: Rothe A; Jachimowicz RD; Borchmann S; Madlener M; Keßler J; Reiners KS; Sauer M; Hansen HP; Ullrich RT; Chatterjee S et al.
Source: Self-asserted source
Sampurna Chatterjee via Europe PubMed Central

Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer.

2014-05 | Journal article
Contributors: Chatterjee S; Wieczorek C; Schöttle J; Siobal M; Hinze Y; Franz T; Florin A; Adamczak J; Heukamp LC; Neumaier B et al.
Source: Self-asserted source
Sampurna Chatterjee via Europe PubMed Central

Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesisin lung cancer.

2013-07 | Journal article
Contributors: Chatterjee S; Heukamp LC; Siobal M; Schöttle J; Wieczorek C; Peifer M; Frasca D; Koker M; König K; Meder L et al.
Source: Self-asserted source
Sampurna Chatterjee via Europe PubMed Central

Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.

2013-04 | Journal article
Contributors: Chatterjee S; Heukamp LC; Siobal M; Schöttle J; Wieczorek C; Peifer M; Frasca D; Koker M; König K; Meder L et al.
Source: Self-asserted source
Sampurna Chatterjee via Europe PubMed Central

Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.

2012-07 | Journal article
Contributors: Heukamp LC; Thor T; Schramm A; De Preter K; Kumps C; De Wilde B; Odersky A; Peifer M; Lindner S; Spruessel A et al.
Source: Self-asserted source
Sampurna Chatterjee via Europe PubMed Central

Cytohesins are cytoplasmic ErbB receptor activators.

2010-10 | Journal article
Contributors: Bill A; Schmitz A; Albertoni B; Song JN; Heukamp LC; Walrafen D; Thorwirth F; Verveer PJ; Zimmer S; Meffert L et al.
Source: Self-asserted source
Sampurna Chatterjee via Europe PubMed Central

Peer review (6 reviews for 4 publications/grants)

Review activity for Cancers. (1)
Review activity for International journal of molecular sciences. (3)
Review activity for Translational oncology. (1)
Review activity for Vaccines. (1)